AstraZeneca’s Portfolio Booms As it Targets 2024 Growth

AstraZeneca’s Portfolio Booms As it Targets 2024 Growth

AstraZeneca PLC is poised for growth in 2024 as its robust portfolio of cancer and rare disease drugs continues to…